Advertisement

Medium to Deep Chemical Peels

  • Suzan Obagi
Chapter

Abstract

Prior to the development of laser resurfacing, chemical peels were among the sole methods by which to resurface the skin. For decades, medium and deep peels have been used to treat a number of skin conditions in ethnically diverse patients. Despite the growing popularity of lasers, peels continue to rank among the most popular cosmetic procedures performed today showing a 4% increase to 1.36 million procedures in the USA during 2016. The two most commonly used acids for medium and deep peels are trichloroacetic acid (TCA) and phenol. The most common indications for chemical peels are actinic keratosis, photodamage, ephelides/lentigines, rhytides, post-inflammatory hyperpigmentation, certain types of acne scars, and melasma. By varying the concentration of the solution or the peeling agent, peels can be used to treat the skin of the neck, chest, and upper extremities.

Keywords

Peel Phenol peel TCA peel Trichloroacetic acid peel Scar Acne scar Melasma Dyschromia Actinic keratosis Chemical peel dyschromia Chemical peel melasma TCA melasma Phenol melasma TCA acne scars CROSS TCA CROSS peel 

References

  1. 1.
  2. 2.
    Stone PA. The use of modified phenol for chemical face peeling. Clin Plast Surg. 1998;25(1):21–44. Review.PubMedGoogle Scholar
  3. 3.
    Hetter GP. An examination of the phenol-croton oil peel: part IV. Face peel results with different concentrations of phenol and croton oil. Plast Reconstr Surg. 2000;105(3):1061–83; discussion 1084–7.CrossRefGoogle Scholar
  4. 4.
    Kumari R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venerol Leprol. 2010;76:447.Google Scholar
  5. 5.
    Puri N. Comparative study of 15% TCA peel versus 35% glycolic acid peel for the treatment of melasma. Indian Dermatol Online J. 2012;3(2):109–13.CrossRefGoogle Scholar
  6. 6.
    Safoury OS, Saki NM, El Nabarawy EA, Farag EA. A study comparing chemical peeling using modified Jessner’s solution and 15% trichloroacetic acid versus 15% trichloroacetic acid in the treatment of melasma. Indian J Dermatol. 2009;54(1):41–5.CrossRefGoogle Scholar
  7. 7.
    Abdel-Meguid AM, Taha EA, Ismail SA. Combined Jessner solution and trichloroacetic acid versus trichloroacetic acid alone in the treatment of melasma in dark-skinned patients. Dermatol Surg. 2017;0:1–6.Google Scholar
  8. 8.
    Soliman MM, Ramadan AR, Bassiouny DA, Abdelmalek M. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study. J Cosmet Dermatol. 2006;6:89–94.CrossRefGoogle Scholar
  9. 9.
    Moubasher AE, Youssef EM, Abou-Taleb DA. Q-switched Nd:YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients. Dermatol Surg. 2014;40:874–82.CrossRefGoogle Scholar
  10. 10.
    Li YT, Yang KC. Comparison of the frequency-doubled Q-switched Nd:YAG laser and 35% trichloroacetic acid for the treatment of face lentigines. Dermatol Surg. 1999;25:202–4.CrossRefGoogle Scholar
  11. 11.
    Raziee M, Balighi K, Shabanzadeh-Dehkordi H, Robati RM. Efficacy and safety of cryotherapy vs. trichloroacetic acid in the treatment of solar lentigo. J Eur Acad Dermatol Venereol. 2008;22(3):316–9.CrossRefGoogle Scholar
  12. 12.
    Holzer G, Pinkowicz A, Radakovic S, Schmidt RB, Tanew A. Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolevulinic acid photodynamic therapy for the treatment of multiple actinic keratosis. Br J Dermatol. 2017 May;176(5):1155–61.Google Scholar
  13. 13.
    Hantash BM, Stewart DB, Cooper ZA, Rehmus WE, Koch RJ, Swetter SM. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol. 2006;142:976–82.PubMedGoogle Scholar
  14. 14.
    Lee JB, Chung WG, Kwahck H, Lee KH. Focal treatment of acne scars with trichloroacetic acid: chemical reconstruction of skin scars method. Dermatol Surg. 2002;28:1017–21.PubMedGoogle Scholar
  15. 15.
    Dalpizzol M, Weber MB, Mattiazzi AP, Manzoni AP. Comparative study of the use of trichloroacetic acid and phenolic acid in the treatment of atrophic-type acne scars. Dematol Surg. 2016;42:377–83.CrossRefGoogle Scholar
  16. 16.
    Ramadan SA, El-Komy MH, Bassiouny DA, El-Tobshy SA. Subcision versus 100% trichloroacetic acid in the treatment of rolling scars. Dermatol Surg. 2011;37:626–33.CrossRefGoogle Scholar
  17. 17.
    Leheta T, El Tawdy A, Hay RA, Farid S. Percutaneous collagen induction versus full-concentration trichloroacetic acid in the treatment of atrophic acne scars. Dermatol Surg. 2011;37:207–16.CrossRefGoogle Scholar
  18. 18.
    Nofal E, Helmy A, Nofal A, Alakad R, Nasr M. Platelet-rich plasma versus CROSS technique with 100% trichloroacetic acid versus combined skin needling and platelet rich plasma in the treatment of atrophic acne scars: a comparative study. Dermatol Surg. 2014;40:864–73.PubMedGoogle Scholar
  19. 19.
    Agarwal N, Gupta LK, Khare AK, Kuldeep CM, Mittal A. Therapeutic response of 70% trichloroacetic acid CROSS in atrophic acne scars. Dermatol Surg. 2015;41:597–604.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Suzan Obagi
    • 1
  1. 1.University of Pittsburgh Medical Center, UPMC Cosmetic Surgery & Skin Health CenterPittsburghUSA

Personalised recommendations